Orion Healthcare Equity Partners is the famous VC, which was founded in 2007. The venture was found in North America in United States. The main department of described VC is located in the Boston.
The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Sanofi-Genzyme BioVentures, Roche Venture Fund, Pfizer Venture Investments. In the next rounds fund is usually obtained by Sanofi-Genzyme BioVentures, Roche Venture Fund, Partners Innovation Fund.
This organization was formed by Mark Carthy.
The high activity for fund was in 2016. The higher amount of exits for fund were in 2017. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline AnTolRx, Lysosomal Therapeutics Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Biotechnology.
Funds with similar focus
Fund Name | Location |
3 Wise Ventures | Delaware, United States, Wilmington |
Capital Fund Management | France, Ile-de-France, Paris |
Co-Share capital | China, Guangdong, Guangzhou |
eFund | Seattle, United States, Washington |
Enterprise Community Investment | Columbia, Maryland, United States |
Epic Labs | Community of Madrid, Madrid, Spain |
Fair4All Finance | England, London, United Kingdom |
HALL Group | Dallas, Texas, United States |
IMechE | England, London, United Kingdom |
Infuse Ventures | Ahmedabad, Gujarat, India |
Invision Capital | Chicago, Illinois, United States |
Luma Launch | California, Santa Monica, United States |
Lumar | Ilford, Redbridge, United Kingdom |
Machem Capital | - |
Misgav Technology Center | HaZafon, Israel, Misgav |
NHN JAPAN | Japan, Tokyo |
SZHTI Group | China, Guangdong, Shenzhen |
Tru Arrow Partners | - |
VisVires New Protein | Central, Central Region, Singapore |
Zhaogang.com | China, Hainan, Yangpu |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
AnTolRx | $4M | 08 Sep 2016 | Cambridge, Massachusetts, United States | ||
Lysosomal Therapeutics | $20M | 03 Feb 2015 | Cambridge, Massachusetts, United States | ||
Lysosomal Therapeutics | $4M | 12 May 2014 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
AnTolRx | $4M | 08 Sep 2016 | Cambridge, Massachusetts, United States | ||
Lysosomal Therapeutics | $20M | 03 Feb 2015 | Cambridge, Massachusetts, United States | ||
Lysosomal Therapeutics | $4M | 12 May 2014 | Cambridge, Massachusetts, United States |